Pay in 4 interest-free payments of $5.17 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
GLP-1 medications can cause profound appetite suppression an effect that, for someone with restrictive eating, can reinforce dangerous patterns of food restriction, reduce food intake to medically dangerous levels, and provide what feels like medical sanction for not eating
Possible temporary GI side effects during dose escalation
Date: June 6, 2026 Source: University of Pennsylvania School of Medicine Summary: A large study found that women taking GLP-1 drugs, the medication class behind Ozempic, Wegovy, Mounjaro, and Zepbound, were about 30% less likely to develop breast cancer
Notably, lorcaserin, a selective 5-HT2C receptor agonist which has been previously been used, was withdrawn from the market in February 2020 due to increased risk of various cancers
US$ 26.13
US$ 24.70
US$ 25.92
US$ 20.21
US$ 25.50
